SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 3,416.17 |
| Enterprise Value ($M) | 3,047.82 |
| Book Value ($M) | 495.50 |
| Book Value / Share | 7.86 |
| Price / Book | 6.89 |
| NCAV ($M) | 489.60 |
| NCAV / Share | 7.76 |
| Price / NCAV | 6.98 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.16 |
| Return on Assets (ROA) | -0.16 |
| Return on Equity (ROE) | -0.16 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 25.51 |
| Current Ratio | 25.51 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 512.32 |
| Assets | 518.21 |
| Liabilities | 22.71 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Fmr Llc | 7.86 | 28.42 | |
| 13D/A | Biotechnology Value Fund L P | 31.40 | -9.19 | |
| 13G/A | Chen Bihua | 14.17 | 23.24 | |
| 13G/A | Citadel Advisors Llc | 3.40 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 34,168 | 134,608 | 25.38 | |
| 53,052 | 192,997 | 27.49 | |
| 38,959 | 187,434 | 20.79 | |
| 56,323 | 235,892 | 23.88 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ME – 23andMe Holding Co. | MEIP – MEI Pharma, Inc. |
| MIRA – MIRA Pharmaceuticals, Inc. | MNPR – Monopar Therapeutics Inc. |
| MRKR – Marker Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io